Although these variants are rare in population and carried in heterozygous condition, these findings suggest that in certain metabolic contexts and diseases in which PLP levels are reduced, the presence of these PDXK variants could threaten genome integrity and contribute to increased cancer risk. The gene discussed is PDXP; the disease is cancer.